BIOMAT Database Logo BIOMAT Database Logo

[Prognostication of tumor reaction to irradiation and individual approach to the use of radiation-modifying agents]. 1986

S P Iarmonenko, and A A Waĭnson, and S V Kozin

UI MeSH Term Description Entries
D008297 Male Males
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D011836 Radiation Tolerance The ability of some cells or tissues to survive lethal doses of IONIZING RADIATION. Tolerance depends on the species, cell type, and physical and chemical variables, including RADIATION-PROTECTIVE AGENTS and RADIATION-SENSITIZING AGENTS. Radiation Sensitivity,Radiosensitivity,Sensitivity, Radiation,Tolerance, Radiation,Radiation Sensitivities,Radiation Tolerances,Radiosensitivities,Sensitivities, Radiation,Tolerances, Radiation
D011837 Radiation-Protective Agents Drugs used to protect against ionizing radiation. They are usually of interest for use in radiation therapy but have been considered for other purposes, e.g. military. Radiation Protectant,Radiation Protective Agent,Radiation-Protective Agent,Radiation-Protective Drug,Radioprotective Agent,Radioprotective Agents,Radioprotective Drug,Agents, Radiation-Protective,Radiation Protectants,Radiation Protective Agents,Radiation-Protective Drugs,Radiation-Protective Effect,Radiation-Protective Effects,Radioprotective Drugs,Agent, Radiation Protective,Agent, Radiation-Protective,Agent, Radioprotective,Agents, Radiation Protective,Agents, Radioprotective,Drug, Radiation-Protective,Drug, Radioprotective,Drugs, Radiation-Protective,Drugs, Radioprotective,Effect, Radiation-Protective,Effects, Radiation-Protective,Protectant, Radiation,Protectants, Radiation,Protective Agent, Radiation,Protective Agents, Radiation,Radiation Protective Drug,Radiation Protective Drugs,Radiation Protective Effect,Radiation Protective Effects
D011838 Radiation-Sensitizing Agents Drugs used to potentiate the effectiveness of radiation therapy in destroying unwanted cells. Radiation Sensitizer,Radiosensitizing Agent,Radiosensitizing Agents,Agents, Radiation-Sensitizing,Radiation Sensitizers,Radiation Sensitizing Agents,Radiation-Sensitizing Drugs,Radiation-Sensitizing Effect,Radiation-Sensitizing Effects,Radiosensitizing Drugs,Radiosensitizing Effect,Radiosensitizing Effects,Agent, Radiosensitizing,Agents, Radiation Sensitizing,Agents, Radiosensitizing,Drugs, Radiation-Sensitizing,Drugs, Radiosensitizing,Effect, Radiation-Sensitizing,Effect, Radiosensitizing,Effects, Radiation-Sensitizing,Effects, Radiosensitizing,Radiation Sensitizing Drugs,Radiation Sensitizing Effect,Radiation Sensitizing Effects,Sensitizer, Radiation,Sensitizers, Radiation,Sensitizing Agents, Radiation
D011879 Radiotherapy Dosage The total amount of radiation absorbed by tissues as a result of radiotherapy. Dosage, Radiotherapy,Dosages, Radiotherapy,Radiotherapy Dosages
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

S P Iarmonenko, and A A Waĭnson, and S V Kozin
[Radiobiological prerequisites in the prognostication of tumor reaction to radiation effects].
December 1986, Meditsinskaia radiologiia,
S P Iarmonenko, and A A Waĭnson, and S V Kozin
[Approaches to the individual prognosis of tumor reaction to radiation and drug exposures].
January 1990, Meditsinskaia radiologiia,
S P Iarmonenko, and A A Waĭnson, and S V Kozin
[Possibilities of prognostication of individual radiation sensitivity].
December 1986, Meditsinskaia radiologiia,
S P Iarmonenko, and A A Waĭnson, and S V Kozin
[Endocrine status in the prognostication of individual radiation sensitivity].
December 1986, Meditsinskaia radiologiia,
S P Iarmonenko, and A A Waĭnson, and S V Kozin
[Systemic radiation reaction of tumor cell populations to high dose irradiation].
January 1997, Radiatsionnaia biologiia, radioecologiia,
S P Iarmonenko, and A A Waĭnson, and S V Kozin
Bone-Modifying Agents: Complicated to Use.
August 2018, Journal of oncology practice,
S P Iarmonenko, and A A Waĭnson, and S V Kozin
[Changes in hemopoiesis in the rat as a result of combined exposure to acceleration, irradiation and radiation-modifying agents].
January 1987, Kosmicheskaia biologiia i aviakosmicheskaia meditsina,
S P Iarmonenko, and A A Waĭnson, and S V Kozin
[Clonal analysis as a method of prognostication of tumor response to irradiation].
December 1986, Meditsinskaia radiologiia,
S P Iarmonenko, and A A Waĭnson, and S V Kozin
[Prognostication of the dose modifying factor in consecutive thermo-radiation exposure of yeast cells].
January 1994, Radiatsionnaia biologiia, radioecologiia,
S P Iarmonenko, and A A Waĭnson, and S V Kozin
[Radiation protection. II. Individual & group exposure to irradiation].
June 1958, Nordisk medicin,
Copied contents to your clipboard!